Requirements for Negative Pre-Departure COVID-19 Test Result or Documentation of Recovery from COVID-19 for Aircraft Passengers Traveling to the United States from the People’s Republic of China
ICR 202212-0920-017 · OMB 0920-1380 · Historical Active
Requirements for Negative Pre-Departure COVID-19 Test Result or Documentation of Recovery from COVID-19 for Aircraft Passengers Traveling to the United States from the Peopleâs Republic of China
New collection (Request for a new OMB Control Number)
No
Emergency
12/29/2022
Approved with change
12/30/2022
12/29/2022
OMB is approving this Emergency ICR with the understanding that within 6 months from the approval date, CDC will complete a 60d and 30d public comment request to support the approval of the ICR ahead of the expiration date.
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
06/30/2023
6 Months From Approved
5,000,020
0
0
5,208,373
0
0
0
0
0
Emergency Information Collection Request is designed to ensure that, consistent with the terms of CDCâs Order Requirements for Negative Pre-Departure COVID-19 Test Result or Documentation of Recovery from COVID-19 for all Airline or Other Aircraft Passengers Traveling to the United States from the Peopleâs Republic of China, air passengers from the Peopleâs Republic of China (PRC) or those boarding in Designated Airports who have been in PRC over the last 10 days show proof of a negative COVID-19 test or documentation of recovery from COVID-19 before boarding a flight to the United States.
Considering the potential danger to public health posed by emerging new variants in the Peopleâs Republic of China, CDC has determined that proactive, preventative measures must be implemented now to protect the U.S. population from potential importation, transmission and spread of new COVID-19 variants into the United States. Pre-departure testing and the requirement to show a negative test result decrease the number of infected passengers boarding airplanes and is a proactive, risk-based approach that will help to slow the spread of COVID-19 as we work to identify and understand any potential new variants that may emerge. Based on the lack of viral genomic sequence data in the Peopleâs Republic of China, this action is needed to allow U.S. public health officials the critical time needed to monitor the unprecedented surge of COVID-19 in the Peopleâs Republic of China effectively and to identify any potential variants of concern.
US Code:
42 USC 264
Name of Law: U.S. PHSA
US Code:
42 USC 71
Name of Law: Foreign Quarantine Regulation
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.